ONCODIANOVA - Trademark Details
Status: 700 - Registered
Serial Number
79250664
Registration Number
5934633
Word Mark
ONCODIANOVA
Status
700 - Registered
Status Date
2019-12-17
Filing Date
2018-07-26
Registration Number
5934633
Registration Date
2019-12-17
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-10-01
Attorney Name
Law Office Assigned Location Code
M10
Employee Name
NADELMAN, ANDREA KOYNE
Statements
Goods and Services
Proteins for use in science; laboratory chemicals, namely, antibodies for scientific purposes, other than for medical or veterinary use; biochemicals, namely, monoclonal antibody reagents, other than for medical use; biochemicals, namely, monoclonal antibodies for scientific use; biochemicals, namely, monoclonal antibodies for diagnostic use other than for medical purposes, in particular for identifying and classifying tumor cells; diagnostic reagents for scientific or research use, other than for medical laboratory use, in particular antibody reagents and monoclonal antibody reagents; hybridomas for producing monoclonal antibodies other than for medical or veterinary purposes
Goods and Services
Medical and veterinary preparations; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical use; diagnostic substances for medical use; clinical diagnostic reagents; in vitro diagnostic preparations for medical use; chemical reagents for medical diagnostic purposes [in particular liquid buffers]; reagents for use in diagnostic tests for medical purposes [in particular antibody reagents and monoclonal antibody reagents]; diagnostic preparations and materials [in particular for pathology, medical histology and in vitro diagnostics], in particular antibodies, monoclonal antibodies, proteins for binding antibodies, proteins for detecting antibodies; diagnostic preparations and materials, in particular monoclonal antibodies for diagnostic use [in particular for identifying and classifying tumour cells]; reagents for developing monoclonal antibodies [for medical, pharmaceutical or veterinary purposes], in particular antigens and immunogens; hybridomas for producing monoclonal antibodies [for medical, pharmaceutical or veterinary purposes]; pharmaceuticals, in particular antibodies [in particular monoclonal antibodies for immunotherapy]
Goods and Services
Retailing and wholesaling [in particular online retail services] in relation to chemical substances, chemical materials and chemical preparations, and natural elements; retailing and wholesaling [in particular online retail services] in relation to chemical compounds and materials for use in science; retailing and wholesaling [in particular online retail services] in relation to medical and veterinary preparations; retailing and wholesaling [in particular online retail services] in relation to proteins, proteins for binding antibodies, proteins for detecting antibodies; retailing and wholesaling [in particular online retail services] in relation to antibodies, monoclonal antibodies [in particular for diagnostic use, in particular for identifying and classifying tumour cells]; retailing and wholesaling [in particular online retail services] in relation to diagnostic preparations and materials, diagnostic preparations, diagnostic reagents [in particular antibody reagents and monoclonal antibody reagents]; retailing and wholesaling [in particular online retail services] in relation to reagents for clinical diagnostics, in vitro diagnostic preparations; retailing and wholesaling [in particular online retail services] in relation to diagnostic substances, chemical reagents for diagnostic tests, liquid buffers, salts [chemical preparations]; retailing and wholesaling [in particular online retail services] in relation to reagents for developing monoclonal antibodies [in particular antigens and immumogens], hybridomas for producing monoclonal antibodies; retailing and wholesaling [in particular online retail services] in relation to pharmaceuticals, in particular antibodies [in particular monoclonal antibodies for immunotherapy]
Goods and Services
Scientific and technological services; research and development services; medical and pharmaceutical research services [in particular in the field of oncology]; research and development in the field of diagnostic preparations, in particular development of antibody-based tests and analyses [in particular for identifying and classifying tumour cells]; research and development in the field of diagnostic preparations, in particular in relation to production of antibody-based tests and analyses [in particular for identifying and classifying tumour cells]; research and development for the pharmaceutical industry [in particular in relation to pharmacological studies and development of therapeutic antibodies]; research and development in the field of biotechnology; research and development services in the field of antibody technology; chemical and biological laboratory services relating to the production of antibodies, in particular development of monoclonal antibodies and in relation to production of monoclonal antibodies [in particular for research and diagnostics], in particular for identifying and classifying tumour cells; research and development in relation to manufacturing and validating immunogens; chemical and biological laboratory services in relation to immunising mice, rats and rabbits; chemical and biological laboratory services in relation to manufacturing, selecting and cloning hybridomas; chemical and biological laboratory services in relation to providing and characterising monoclonal antibodies; consultancy and information in relation to the aforesaid services, included in this class
Goods and Services
Medical services; medical testing services relating to the diagnosis and treatment of disease [in particular in the field of oncology]; medical diagnostic services [conducting of tests and analyses, in particular in the fields of pathology, medical histology and in vitro diagnostics], in particular conducting of antibody-based tests and analyses; medical diagnostic services [conducting of tests and analyses], in particular immunohistochemical and microscopic tests and analyses, in particular for identifying and classifying tumour cells; consultancy and information in relation to the aforesaid services, included in this class; consultancy and information services relating to biopharmaceutical products; consultancy and information services relating to medical products; consultancy and information services relating to pharmaceutical products
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2019-02-05
Primary Code
001
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited liability company (GmbH)).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited liability company (GmbH)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (limited liability company (GmbH)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
11 - 1st New Owner Before Publication
Legal Entity Type
99 - Other (limited liability company (GmbH)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Thilo C. Agthe
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1446813
International Registration Date
2018-07-26
International Publication Date
2019-01-31
International Renewal Date
2028-07-26
Auto Protection Date
2020-07-31
International Status
001 - Request for extension of protection established
International Status Date
2019-01-31
Priority Claimed In
True
Priority Claimed Date
2018-02-11
First Refusal In
True
Trademark Events
Event Date | Event Description |
2019-01-31 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2019-02-05 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-02-05 | ASSIGNED TO EXAMINER |
2019-02-07 | NON-FINAL ACTION WRITTEN |
2019-02-08 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2019-02-09 | APPLICATION FILING RECEIPT MAILED |
2019-02-19 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
2019-02-20 | NON-FINAL ACTION WRITTEN |
2019-02-21 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2019-02-28 | REFUSAL PROCESSED BY MPU |
2019-02-28 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2019-03-16 | REFUSAL PROCESSED BY IB |
2019-05-10 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2019-05-10 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2019-07-04 | CHANGE OF OWNER RECEIVED FROM IB |
2019-08-05 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-08-14 | ASSIGNED TO LIE |
2019-08-14 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-08-14 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-08-29 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-09-11 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2019-09-18 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2019-09-18 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2019-10-01 | PUBLISHED FOR OPPOSITION |
2019-10-01 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2019-10-05 | NOTIFICATION PROCESSED BY IB |
2019-12-17 | REGISTERED-PRINCIPAL REGISTER |
2020-03-17 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2020-03-28 | FINAL DISPOSITION PROCESSED |
2020-03-28 | FINAL DISPOSITION NOTICE SENT TO IB |
2020-04-17 | FINAL DECISION TRANSACTION PROCESSED BY IB |